Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6986 results

Sort By:

Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)

Study ID: NCT07120945
Start Date: 2025-08-28
End Date: 2031-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

70

Intervention / Treatment

Robotic Assisted-Surgery (RAS) Hysterectomy

Sponsor

Medtronic - MITG

Source: clinicaltrials.gov

Share:
Add to list

99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT

Study ID: NCT05891769
Start Date: 2023-09-27
End Date: 2027-07-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

100

Intervention / Treatment

18Fluorocholine

Sponsor

Andrei Iagaru

Source: clinicaltrials.gov

Share:
Add to list

Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell Carcinoma

Study ID: NCT06161545
Start Date: 2025-09-24
End Date: 2028-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

PD-L1 t-haNK cells

pembrolizumab

N-803

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence

Study ID: NCT04763109
Start Date: 2022-07-08
End Date: 2027-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

15

Intervention / Treatment

Whole-body Magnetic Resonance Imaging

Sponsor

Nicole Baca

Source: clinicaltrials.gov

Share:
Add to list

A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer

Study ID: NCT06046495
Start Date: 2024-07-08
End Date: 2028-02-09
Study Type

Interventional

Study Phase

Phase1

No. of Participants

81

Intervention / Treatment

PLB1004

Sponsor

Avistone Biotechnology Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation

Study ID: NCT06799195
Start Date: 2025-06-23
End Date: 2031-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

126

Intervention / Treatment

Attenuated-dose Cyclophosphamide

High-dose Cyclophosphamide

Sirolimus

Mycophenolate Mofetil (MMF)

Sponsor

University of Nebraska

Source: clinicaltrials.gov

Share:
Add to list

Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

Study ID: NCT03786692
Start Date: 2019-09-04
End Date: 2028-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

117

Intervention / Treatment

Arm A

Arm B

Sponsor

Fox Chase Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

Study ID: NCT06326411
Start Date: 2024-04-09
End Date: 2029-11
Study Type

Interventional

Study Phase

Phase1

No. of Participants

230

Intervention / Treatment

NST-628

Sponsor

Nested Therapeutics, Inc

Source: clinicaltrials.gov

Share:
Add to list

A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors

Study ID: NCT05963971
Start Date: 2024-03-19
End Date: 2027-06-23
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

376

Intervention / Treatment

PEDAL

Standard of care

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis

Study ID: NCT06064695
Start Date: 2023-07-12
End Date: 2025-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

16

Intervention / Treatment

Whole-body Electrical Muscle Stimulation Exercise

Sponsor

University of Missouri-Columbia

Source: clinicaltrials.gov

Share:
Add to list